Mortality after first myocardial infarction in Greek patients: a 4-year follow-up study

Genovefa D Kolovou1, Constantinos Mihas, Anastasia Kotanidou

  • 1First Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece. genovefa@kolovou.com

Angiology
|August 13, 2009
PubMed

Insights

Smoking cessation and increased physical activity are crucial for coronary heart disease (CHD) survivors after myocardial infarction (MI). Early intervention in antismoking programs can improve outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary heart disease (CHD) mortality is influenced by time since myocardial infarction (MI) and risk factor management.
  • Understanding post-MI survival factors is critical for patient outcomes.

Purpose of the Study:

  • To investigate mortality risk factors in patients following myocardial infarction (MI).
  • To identify lifestyle and medical factors associated with long-term survival after MI.

Main Methods:

  • Observational, retrospective 4-year follow-up study.
  • 804 patients (628 men) completed questionnaires on lifestyle, medical history, and medications.
  • Data analyzed for associations with mortality.

Main Results:

  • 12% of men and 15% of women died during follow-up.
  • Older age, longer smoking duration, and exercise frequency differed significantly between survivors and deceased.
  • Multivariate analysis linked increased smoking years and nitrate treatment to higher mortality, while increased exercise frequency was associated with lower mortality.

Conclusions:

  • Emphasize smoking cessation and increased physical activity for MI survivors.
  • Implement antismoking programs starting at an early age to improve long-term prognosis.
Abstract

Related Concept Videos

Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...